Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Collen

Showing results (311-320 of 715) with videos related to

Pageof 72
Sort By:
Circulation|January 7, 1998
Effects of adenovirus-mediated human apo A-I gene transfer on neointima formation after endothelial denudation in apo E-deficient miceB De Geest, Z Zhao, D Collen, et al.
Biochimica Et Biophysica Acta|September 29, 1977
Identification of the human plasma protein which inhibits fibrinolysis associated with malignant cellsD Collen, A Billiau, J Edy, et al.
The Journal of Biological Chemistry|April 10, 1982
Preparation, characterization, and turnover properties of heparin-antithrombin III complexes stabilized by covalent bondsR Ceustermans, M Hoylaerts, M De Mol, et al.
The Journal of Clinical Investigation|April 1, 1985
Antithrombotic properties in rabbits of heparin and heparin fragments covalently coupled to human antithrombin IIIC Mattsson, M Hoylaerts, E Holmer, et al.
Blood|April 16, 1998
Stromelysin-1 (MMP-3)-independent gelatinase expression and activation in miceH R Lijnen, J Silence, B Van Hoef, et al.
Journal of Cardiovascular Pharmacology|April 1, 1992
Stimulation by retinoids of tissue-type plasminogen activator secretion in cultured human endothelial cells: relations of structure to effectF Bulens, L Nelles, N Van den Panhuyzen, et al.
Journal of Thrombosis and Haemostasis : JTH|January 14, 2004
Neointima formation and thrombosis after vascular injury in transgenic mice overexpressing plasminogen activator inhibitor-1 (PAI-1)H R Lijnen, B Van Hoef, K Umans, et al.
The Journal of Biological Chemistry|April 25, 1988
Biochemical and thrombolytic properties of a low molecular weight form (comprising Leu144 through Leu411) of recombinant single-chain urokinase-type plasminogen activatorH R Lijnen, L Nelles, W E Holmes, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 10, 2000
Alpha(2)-antiplasmin gene deficiency in mice does not affect neointima formation after vascular injuryH R Lijnen, B Van Hoef, M Dewerchin, et al.
European Journal of Biochemistry|September 15, 1994
Characterization of the murine plasma fibrinolytic systemH R Lijnen, B van Hoef, V Beelen, et al.
Pageof 72

Showing results (311-320 of 715) with videos related to

Sort By:
Pageof 72
Circulation|January 7, 1998
Effects of adenovirus-mediated human apo A-I gene transfer on neointima formation after endothelial denudation in apo E-deficient miceB De Geest, Z Zhao, D Collen, et al.
Biochimica Et Biophysica Acta|September 29, 1977
Identification of the human plasma protein which inhibits fibrinolysis associated with malignant cellsD Collen, A Billiau, J Edy, et al.
The Journal of Biological Chemistry|April 10, 1982
Preparation, characterization, and turnover properties of heparin-antithrombin III complexes stabilized by covalent bondsR Ceustermans, M Hoylaerts, M De Mol, et al.
The Journal of Clinical Investigation|April 1, 1985
Antithrombotic properties in rabbits of heparin and heparin fragments covalently coupled to human antithrombin IIIC Mattsson, M Hoylaerts, E Holmer, et al.
Blood|April 16, 1998
Stromelysin-1 (MMP-3)-independent gelatinase expression and activation in miceH R Lijnen, J Silence, B Van Hoef, et al.
Journal of Cardiovascular Pharmacology|April 1, 1992
Stimulation by retinoids of tissue-type plasminogen activator secretion in cultured human endothelial cells: relations of structure to effectF Bulens, L Nelles, N Van den Panhuyzen, et al.
Journal of Thrombosis and Haemostasis : JTH|January 14, 2004
Neointima formation and thrombosis after vascular injury in transgenic mice overexpressing plasminogen activator inhibitor-1 (PAI-1)H R Lijnen, B Van Hoef, K Umans, et al.
The Journal of Biological Chemistry|April 25, 1988
Biochemical and thrombolytic properties of a low molecular weight form (comprising Leu144 through Leu411) of recombinant single-chain urokinase-type plasminogen activatorH R Lijnen, L Nelles, W E Holmes, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 10, 2000
Alpha(2)-antiplasmin gene deficiency in mice does not affect neointima formation after vascular injuryH R Lijnen, B Van Hoef, M Dewerchin, et al.
European Journal of Biochemistry|September 15, 1994
Characterization of the murine plasma fibrinolytic systemH R Lijnen, B van Hoef, V Beelen, et al.
Pageof 72